Leu J I, Crissey M A, Leu J P, Ciliberto G, Taub R
Department of Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Mol Cell Biol. 2001 Jan;21(2):414-24. doi: 10.1128/MCB.21.2.414-424.2001.
Following hepatic injury or stress, gluconeogenic and acute-phase response genes are rapidly upregulated to restore metabolic homeostasis and limit tissue damage. Regulation of the liver-restricted insulin-like growth factor binding protein 1 (IGFBP-1) gene is dramatically altered by changes in the metabolic state and hepatectomy, and thus it provided an appropriate reporter to assess the transcriptional milieu in the liver during repair and regeneration. The cytokine interleukin-6 (IL-6) is required for liver regeneration and repair, and it transcriptionally upregulates a vast array of genes during liver growth by unknown mechanisms. Evidence for a biologic role of IL-6 in IGFBP-1 upregulation was demonstrated by increased expression of hepatic IGFBP-1 in IL-6 transgenic and following injection of IL-6 into nonfasting animals and its reduced expression in IL-6(-/-) livers posthepatectomy. In both hepatic and nonhepatic cells, IL-6 -mediated IGFBP-1 promoter activation was via an intact hepatocyte nuclear factor 1 (HNF-1) site and was dependent on the presence of endogenous liver factor HNF-1 and induced factors STAT3 and AP-1 (c-Fos/c-Jun). IL-6 acted through the STAT3 pathway, as dominant negative STAT3 completely blocked IL-6-mediated stimulation of the IGFBP-1 promoter via the HNF-1 site. HNF-1/c-Fos and HNF-1/STAT3 protein complexes were detected in mouse livers and in hepatic and nonhepatic cell lines overexpressing STAT3/c-Fos/HNF-1. Similar regulation was demonstrated using glucose-6-phosphatase and alpha-fibrinogen promoters, indicating that HNF-1/IL-6/STAT3/AP-1-mediated transactivation of hepatic gene expression is a general phenomenon after liver injury. These results demonstrate that the two classes of transcription factors, growth induced (STAT3 and AP-1) and tissue specific (HNF-1), can interact as an adaptive response to liver injury to amplify expression of hepatic genes important for the homeostatic response during organ repair.
在肝脏损伤或应激后,糖异生和急性期反应基因迅速上调,以恢复代谢稳态并限制组织损伤。肝脏特异性胰岛素样生长因子结合蛋白1(IGFBP-1)基因的调控会因代谢状态的改变和肝切除术而发生显著变化,因此它为评估肝脏在修复和再生过程中的转录环境提供了一个合适的报告基因。细胞因子白细胞介素-6(IL-6)是肝脏再生和修复所必需的,它通过未知机制在肝脏生长过程中转录上调大量基因。在IL-6转基因小鼠中,以及向非禁食动物注射IL-6后,肝脏IGFBP-1的表达增加,而在肝切除术后IL-6基因敲除(IL-6(-/-))小鼠的肝脏中其表达降低,这证明了IL-6在IGFBP-1上调中具有生物学作用。在肝细胞和非肝细胞中,IL-6介导的IGFBP-1启动子激活均通过完整的肝细胞核因子1(HNF-1)位点,并且依赖于内源性肝脏因子HNF-1以及诱导因子信号转导和转录激活因子3(STAT3)和激活蛋白-1(AP-1,即c-Fos/c-Jun)的存在。IL-6通过STAT3途径发挥作用,因为显性负性STAT3完全阻断了IL-6通过HNF-1位点介导的IGFBP-1启动子刺激。在小鼠肝脏以及过表达STAT3/c-Fos/HNF-1的肝细胞和非肝细胞系中检测到了HNF-1/c-Fos和HNF-1/STAT3蛋白复合物。使用葡萄糖-6-磷酸酶和α-纤维蛋白原启动子也证明了类似的调控,这表明HNF-1/IL-6/STAT3/AP-1介导的肝脏基因表达反式激活是肝脏损伤后的普遍现象。这些结果表明,两类转录因子,即生长诱导型(STAT3和AP-1)和组织特异性型(HNF-1),可以相互作用,作为对肝脏损伤的适应性反应,以放大对器官修复过程中稳态反应重要的肝脏基因的表达。